MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathwayJiecheng Ye(Jinan University), Lihui Wang(Jinan University)International Journal of OncologyJune 21, 202210.3892/ijo.2022.5384Cited by 7SaveCiteExport RISWatch citationsRelated PapersVasorin stimulates malignant progression and angiogenesis in glioma|Cancer Science|2019|50MELK Predicts Poor Prognosis and Promotes Metastasis in Esophageal Squamous Cell Carcinoma Via Activating the NF-κB Pathway|Research Square|2021|1